These reforms also apply to horses stabled at Keeneland’s The Thoroughbred Center in Lexington and the Churchill Downs Training Center in Louisville.

In a significant step to promote integrity in racing, Keeneland and Churchill Downs will ban the race-day use of Lasix in all 2-year-old races under the International Medication Protocol authority granted in 810 KAR 8:050 of the Kentucky Administrative Regulations beginning with Keeneland’s 2020 Spring Meet and following at Churchill Downs Racetrack’s 2020 Spring Meet. Kentucky’s Thoroughbred race tracks supported sweeping medication reforms, including the Lasix ban, adopted by the Kentucky Horse Racing Commission (KHRC) in late 2019.

Changes will become effective with the opening of the stable areas at Keeneland and Churchill Downs. Trainers and attending veterinarians must agree to the following conditions in order to participate in the racing programs at either track:

A trainer is not permitted to enter a horse in any race unless the horse has been found fit to race by the attending veterinarian during the three days immediately prior to entry, and

A trainer is not permitted to work a horse unless the horse has been found fit to work by the attending veterinarian during the five days immediately before the work.

Trainers and attending veterinarians are obligated to inform the equine medical director at the appropriate race track and the KHRC of any changes in a horse’s fitness after an examination has been conducted.

Additionally, all horses at Keeneland and Churchill Downs will be subject to veterinary inspections by the tracks’ respective equine medical directors and to veterinary monitoring.